JPMorgan Chase & Co. set a $128.00 price objective on Monsanto Co. (NYSE:MON) in a research report report published on Thursday morning. The firm currently has a a buy rating on the stock.
Other equities analysts have also recently issued research reports about the company. Piper Jaffray Cos. restated an overweight rating and issued a $127.00 price target (up previously from $95.00) on shares of Monsanto in a report on Monday, June 13th. Zacks Investment Research cut Monsanto from a hold rating to a strong sell rating in a report on Friday. Argus restated a buy rating and issued a $128.00 price target (up previously from $111.00) on shares of Monsanto in a report on Wednesday, June 15th. Vetr upgraded Monsanto from a buy rating to a strong-buy rating and set a $122.43 price target for the company in a report on Tuesday, August 9th. Finally, Goldman Sachs Group Inc. set a $92.00 price target on Monsanto and gave the stock a sell rating in a report on Monday, June 27th. Three investment analysts have rated the stock with a sell rating, eight have given a hold rating, fifteen have assigned a buy rating and one has issued a strong buy rating to the stock. The stock currently has an average rating of Buy and a consensus price target of $114.67.
Shares of Monsanto (NYSE:MON) traded down 0.10% during trading on Thursday, hitting $103.40. 1,633,739 shares of the stock were exchanged. The stock has a market cap of $45.25 billion, a PE ratio of 45.51 and a beta of 1.19. Monsanto has a one year low of $83.73 and a one year high of $114.26. The stock’s 50 day moving average price is $104.88 and its 200 day moving average price is $101.34.
Monsanto (NYSE:MON) last issued its earnings results on Wednesday, October 5th. The company reported $0.07 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of ($0.02) by $0.09. Monsanto had a return on equity of 46.07% and a net margin of 9.89%. The business earned $2.56 billion during the quarter, compared to analysts’ expectations of $2.38 billion. During the same quarter in the previous year, the business earned ($0.19) EPS. The company’s revenue for the quarter was up 8.8% on a year-over-year basis. Equities research analysts predict that Monsanto will post $4.89 EPS for the current year.
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 28th. Investors of record on Friday, October 7th will be paid a $0.54 dividend. This represents a $2.16 annualized dividend and a yield of 2.09%. The ex-dividend date is Wednesday, October 5th. Monsanto’s dividend payout ratio is currently 71.05%.
In related news, CEO Michael K. Stern sold 12,797 shares of the stock in a transaction dated Wednesday, July 13th. The stock was sold at an average price of $101.77, for a total value of $1,302,350.69. Following the completion of the sale, the chief executive officer now directly owns 21,583 shares of the company’s stock, valued at approximately $2,196,501.91. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, COO Brett D. Begemann sold 27,980 shares of the stock in a transaction dated Thursday, July 14th. The stock was sold at an average price of $103.62, for a total value of $2,899,287.60. Following the completion of the sale, the chief operating officer now directly owns 102,480 shares of the company’s stock, valued at $10,618,977.60. The disclosure for this sale can be found here. 0.88% of the stock is owned by corporate insiders.
A number of large investors have recently made changes to their positions in the company. WFG Advisors LP increased its stake in shares of Monsanto by 18.6% in the second quarter. WFG Advisors LP now owns 1,009 shares of the company’s stock valued at $104,000 after buying an additional 158 shares in the last quarter. Signaturefd LLC increased its stake in Monsanto by 62.1% in the second quarter. Signaturefd LLC now owns 1,083 shares of the company’s stock worth $112,000 after buying an additional 415 shares during the period. Mycio Wealth Partners LLC increased its stake in Monsanto by 1.1% in the second quarter. Mycio Wealth Partners LLC now owns 1,094 shares of the company’s stock worth $113,000 after buying an additional 12 shares during the period. Pinkerton Retirement Specialists LLC increased its stake in Monsanto by 1,179.1% in the second quarter. Pinkerton Retirement Specialists LLC now owns 1,100 shares of the company’s stock worth $114,000 after buying an additional 1,014 shares during the period. Finally, Carnick & Kubik LLC purchased a new stake in Monsanto during the first quarter worth $130,000. 79.02% of the stock is owned by hedge funds and other institutional investors.
Monsanto Company Profile